SELLAS Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S.

CEO

Angelos M. Stergiou

CEOAngelos M. Stergiou

Employees

Employees15

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2006

Founded2006

Employees

Employees15

SLS Key Statistics

Market cap

160.14M

Market cap160.14M

Price-Earnings ratio

-4.09

Price-Earnings ratio-4.09

Dividend yield

—

Dividend yield—

Average volume

2.65M

Average volume2.65M

High today

$1.63

High today$1.63

Low today

$1.51

Low today$1.51

Open price

$1.54

Open price$1.54

Volume

2.51M

Volume2.51M

52 Week high

$1.85

52 Week high$1.85

52 Week low

$0.772

52 Week low$0.772

SLS News

TipRanks 13h

Promising Catalysts and Strong Financial Position Drive Buy Rating for SELLAS Life Sciences Group

SELLAS Life Sciences Group (SLS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from...

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.

Tonix Pharmaceuticals